Classically, CE is diagnosed by identifying the presence of CD138‐positive plasma cells in the endometrial stroma through immunohistochemical staining for CD138108; however, this finding is not specific, and its effectiveness can vary depending on the menstrual cycle. This evidence concerns the gene SDC1 and cholesteryl ester measurement.